Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Alk Abello A/S: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

12 Apr 2014 Reuters Investment Profile 12 $20.00

ALK-Abello AS

ALK-Abello AS - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the c...

08 Apr 2014 MarketLine (a Datamonitor Company) 35 $175.00

ALK-Abello A/S (ALK B) - Financial and Strategic SWOT Analysis Review

ALK-Abello A/S (ALK B) - Financial and Strategic SWOT Analysis Review Summary ALK-Abello A/S (ALK) is a research-driven pharm...

02 Apr 2014 GlobalData 40 $125.00

Wright Investors Service Comprehensive Report for ALK-Abello A/S

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

31 Mar 2014 Wright Reports 42 $75.00

ALK-Abello A/S (ALK B) - Financial and Strategic SWOT Analysis Review

ALK-Abello A/S (ALK B) - Financial and Strategic SWOT Analysis Review Summary ALK-Abello A/S (ALK) is a research-driven pharm...

24 Mar 2014 GlobalData 37 $125.00

ALK-Abello A/S (ALK B) - Financial and Strategic SWOT Analysis Review

ALK-Abello A/S (ALK B) - Financial and Strategic SWOT Analysis Review Summary ALK-Abello A/S (ALK) is a research-driven pharm...

05 Feb 2014 GlobalData 37 $125.00

ALK-Abello A/S (ALK B) - Financial and Strategic SWOT Analysis Review

ALK-Abello A/S (ALK B) - Financial and Strategic SWOT Analysis Review Summary ALK-Abello A/S (ALK) is a research-driven pharm...

10 Jan 2014 GlobalData 37 $125.00

ALK-Abello A/S (ALK B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ALK-Abello A/S (ALK B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary ALK-Abello A/S (ALK) is a researc...

26 Dec 2013 GlobalData 28 $250.00

ALK-ABELLÓ - UNANIMOUS FDA ADCOMM VOTE FOR GRASTEK

The US FDA Allergenic Products Advisory Committee Meeting (APAC) voted unanimously in favour of ALK and partner Merck’s Grast...

19 Dec 2013 Edison Investment Research 2 $10.00

ALK-Abello A/S (ALK B) - Financial and Strategic SWOT Analysis Review

ALK-Abello A/S (ALK B) - Financial and Strategic SWOT Analysis Review Summary ALK-Abello A/S (ALK) is a research-driven pharm...

26 Nov 2013 GlobalData 39 $125.00